SG11201912625QA - Modified l-asparaginase - Google Patents
Modified l-asparaginaseInfo
- Publication number
- SG11201912625QA SG11201912625QA SG11201912625QA SG11201912625QA SG11201912625QA SG 11201912625Q A SG11201912625Q A SG 11201912625QA SG 11201912625Q A SG11201912625Q A SG 11201912625QA SG 11201912625Q A SG11201912625Q A SG 11201912625QA SG 11201912625Q A SG11201912625Q A SG 11201912625QA
- Authority
- SG
- Singapore
- Prior art keywords
- asparaginase
- modified
- Prior art date
Links
- 102100025573 1-alkyl-2-acetylglycerophosphocholine esterase Human genes 0.000 title 1
- 108010024976 Asparaginase Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
- C12N9/82—Asparaginase (3.5.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
- C12Y305/01001—Asparaginase (3.5.1.1)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762523061P | 2017-06-21 | 2017-06-21 | |
| EP17177237.9A EP3418383A1 (en) | 2017-06-21 | 2017-06-21 | Modified l-asparaginase |
| US15/671,086 US10174302B1 (en) | 2017-06-21 | 2017-08-07 | Modified L-asparaginase |
| PCT/EP2018/066647 WO2018234492A1 (en) | 2017-06-21 | 2018-06-21 | L-ASPARAGINASE MODIFIED |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201912625QA true SG11201912625QA (en) | 2020-01-30 |
Family
ID=64737515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201912625QA SG11201912625QA (en) | 2017-06-21 | 2018-06-21 | Modified l-asparaginase |
Country Status (14)
| Country | Link |
|---|---|
| EP (2) | EP3642340B1 (es) |
| JP (2) | JP2020528743A (es) |
| KR (1) | KR20200030065A (es) |
| CN (1) | CN111315878B (es) |
| AU (1) | AU2018287145B2 (es) |
| BR (1) | BR112019027479A2 (es) |
| CA (1) | CA3068100A1 (es) |
| DK (1) | DK3642340T3 (es) |
| FI (1) | FI3642340T3 (es) |
| IL (1) | IL271504B2 (es) |
| MX (1) | MX2019015502A (es) |
| SA (1) | SA519410870B1 (es) |
| SG (1) | SG11201912625QA (es) |
| WO (1) | WO2018234492A1 (es) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11400065B2 (en) | 2019-03-01 | 2022-08-02 | Flamel Ireland Limited | Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3919623A1 (en) | 2015-12-22 | 2021-12-08 | XL-protein GmbH | Nucleic acids encoding repetitive amino acid sequences rich in proline and alanine residues that have low repetitive nucleotide sequences |
| UY37341A (es) | 2016-07-22 | 2017-11-30 | Flamel Ireland Ltd | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada |
| US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11986451B1 (en) | 2016-07-22 | 2024-05-21 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| WO2019101308A1 (en) * | 2017-11-22 | 2019-05-31 | Merz Pharma Gmbh & Co. Kgaa | Novel recombinant botulinum toxin with increased duration of effect |
| TW202241922A (zh) * | 2020-12-23 | 2022-11-01 | 愛爾蘭商爵士製藥愛爾蘭有限公司 | 純化電荷遮蔽的融合蛋白質之方法 |
| US20220313798A1 (en) | 2021-03-30 | 2022-10-06 | Jazz Pharmaceuticals Ireland Ltd. | Dosing of recombinant l-asparaginase |
| US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
| WO2024015529A2 (en) | 2022-07-14 | 2024-01-18 | Jazz Pharmaceuticals Ireland Ltd. | Combination therapies involving l-asparaginase |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
| GB8519753D0 (en) * | 1985-08-06 | 1985-09-11 | Health Lab Service Board | Production of 1-asparaginase |
| WO2007103290A2 (en) | 2006-03-03 | 2007-09-13 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Materials and methods directed to asparagine synthetase and asparaginase therapies |
| EP2851424B1 (en) * | 2007-03-09 | 2016-09-21 | Novozymes A/S | Thermostable asparaginases |
| DK2173890T3 (da) | 2007-06-21 | 2011-06-27 | Univ Muenchen Tech | Biologisk aktive proteiner med forhøjet stabilitet in vivo og/eller in vitro |
| WO2011003633A1 (en) * | 2009-07-06 | 2011-01-13 | Alize Pharma Ii | Pegylated l-asparaginase |
| WO2011144756A1 (en) | 2010-05-21 | 2011-11-24 | Xl-Protein Gmbh | Biosynthetic proline/alanine random coil polypeptides and their uses |
| CN107496932A (zh) | 2012-02-27 | 2017-12-22 | 阿穆尼克斯运营公司 | Xten缀合组合物和制造其的方法 |
-
2018
- 2018-06-21 KR KR1020207002029A patent/KR20200030065A/ko not_active Application Discontinuation
- 2018-06-21 EP EP18731853.0A patent/EP3642340B1/en active Active
- 2018-06-21 AU AU2018287145A patent/AU2018287145B2/en active Active
- 2018-06-21 MX MX2019015502A patent/MX2019015502A/es unknown
- 2018-06-21 IL IL271504A patent/IL271504B2/en unknown
- 2018-06-21 CA CA3068100A patent/CA3068100A1/en active Pending
- 2018-06-21 CN CN201880054251.4A patent/CN111315878B/zh active Active
- 2018-06-21 EP EP22204187.3A patent/EP4180525A1/en active Pending
- 2018-06-21 WO PCT/EP2018/066647 patent/WO2018234492A1/en active Application Filing
- 2018-06-21 SG SG11201912625QA patent/SG11201912625QA/en unknown
- 2018-06-21 DK DK18731853.0T patent/DK3642340T3/da active
- 2018-06-21 BR BR112019027479-0A patent/BR112019027479A2/pt unknown
- 2018-06-21 JP JP2019571042A patent/JP2020528743A/ja active Pending
- 2018-06-21 FI FIEP18731853.0T patent/FI3642340T3/fi active
-
2019
- 2019-12-21 SA SA519410870A patent/SA519410870B1/ar unknown
-
2023
- 2023-02-28 JP JP2023030460A patent/JP2023081915A/ja active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11400065B2 (en) | 2019-03-01 | 2022-08-02 | Flamel Ireland Limited | Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111315878B (zh) | 2024-04-26 |
| IL271504A (en) | 2020-02-27 |
| EP4180525A1 (en) | 2023-05-17 |
| IL271504B2 (en) | 2024-05-01 |
| SA519410870B1 (ar) | 2023-03-06 |
| KR20200030065A (ko) | 2020-03-19 |
| JP2023081915A (ja) | 2023-06-13 |
| AU2018287145A1 (en) | 2020-02-06 |
| IL271504B1 (en) | 2024-01-01 |
| EP3642340B1 (en) | 2024-03-20 |
| RU2020101972A (ru) | 2021-07-21 |
| RU2020101972A3 (es) | 2021-11-09 |
| AU2018287145B2 (en) | 2024-04-18 |
| CN111315878A (zh) | 2020-06-19 |
| FI3642340T3 (fi) | 2024-06-18 |
| JP2020528743A (ja) | 2020-10-01 |
| CA3068100A1 (en) | 2018-12-27 |
| BR112019027479A2 (pt) | 2020-09-15 |
| MX2019015502A (es) | 2020-07-28 |
| DK3642340T3 (da) | 2024-06-03 |
| EP3642340A1 (en) | 2020-04-29 |
| WO2018234492A1 (en) | 2018-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3606954T3 (en) | Anti-LAG3-antistoffer | |
| IL271504A (en) | Modified L-asparaginase | |
| DK3734167T3 (en) | Airconditionsystem | |
| DK3499914T3 (en) | Høreapparatsystem | |
| DK3700925T3 (en) | Hidtil ukendt t-cellereceptor | |
| IL273493A (en) | Modified CAR-T | |
| DK3615457T3 (en) | Transportcontainer | |
| AU201714106S (en) | Mandoline | |
| EP3684343C0 (en) | IMPROVED SUPRAPARTICLES | |
| PL3704146T3 (pl) | Przeciwciało Contorsbody trifab | |
| DK3630041T3 (en) | Stimulationsapparat | |
| DK3401557T3 (en) | Træskrue | |
| IL272526A (en) | Enhanced endoinulinase proteins | |
| DK3485765T3 (en) | Computerbord | |
| GB201700825D0 (en) | Poliovaccine | |
| DK3704866T3 (en) | Datatransmissionssystem | |
| GB201707210D0 (en) | Improved hitchlock | |
| DK3425793T3 (en) | Tagsystem | |
| DK3618761T3 (en) | Intrakorporalt perfusionssystem | |
| DK3351149T3 (en) | Syltetøjsfontæne | |
| IL256575A (en) | Daburech | |
| GB201710624D0 (en) | RedCloud BB10 | |
| GB201707508D0 (en) | Modified bulgeomers | |
| AU201715236S (en) | Striplight | |
| GB201703034D0 (en) | Modified bulgeomers |